부산대학교 도서관

Bone defects affect many people and impose expenses of costly treatment with possible complications. This study aims to investigate a novel Poly (𝜀-caprolactone)/Poly (L-lactic) acid/Gelatin nanofiber [PCL/PLA/GNF] scaffold containing 5% resveratrol (Resv) which was manufactured via thermally induced phase separation technique (TIPS), and its applicability for bone defect treatment. Gelatin nanofiber (GNF) was synthesized via the electrospinning method and mixed with PCL/PLA solution and then 5% resveratrol was added to fabricate a 3D scaffold via the TIPS technique. The prepared scaffolds were evaluated regarding their porosity, morphology, contact angle, degradation properties, biomechanical, blood compatibility, and cell viability via MTT assay. The scaffolds were further investigated by implantation in a rat femur defect model. PCL/PLA/GNF with 5% Resv showed a cancellated structure with irregular-shaped pores. The mean pore size was estimated to be 160 μm and the porosity was 80.56 ± 2.68%. The contact angle of the fabricated scaffold was 95.4 ± 3.4, which determines the hydrophobic nature of the scaffold. Increased cell viability in scaffolds was observed by adding resveratrol. Twelve weeks after the implantation of the scaffold into the bone defect, the defects filled with PCL/PLA/GNF-resveratrol contained scaffold were remarkably better than PCL/PLA/GNF and negative control group (89.23 ± 6.34% in 12 weeks), and the difference was significant (p ¡ 0.05). In conclusion, the PCL/PLA/GNF scaffold containing 5% of resveratrol demonstrated adequate mechanical and physical properties. There is possible applicability of PCL/PLA/GNF scaffold containing 5% of resveratrol for surgical treatment of bone defects.